11th Edition Biologics Formulation Development and Drug Delivery

Event Details

Start Date
Thu, 22 Oct 2020
End Date
Fri, 23 Oct 2020
Share This Page

This marcus evans event will provide attendees with a more coherent, efficient, and comprehensive view on the whole formulation process (from preformulation through to production, manufacturing, and delivery). They will benefit from case studies on major challenges such as aggregates, particles, bioavailability, immunogenicity, and compatibility; and will learn how to minimise risks, time, and expenditure.

Protein formulation development is a challenging process which ultimately determines the effectiveness and profitability of the final protein drug. Proteins are complex and fragile molecules which are not easy to identify, comprehend, and most of all, to stabilise in the long term. These are the main parameters for a drug to be accepted by regulators and scientists also have to think one step ahead to look at the impacts of formulation on manufacturing and drug delivery. Besides the complexity of proteins, formulation needs to be robust and count on clear processes which can guarantee the quality of the product, reproducibility, efficacy in fighting against targeted cells, and stability throughout the whole process. Thanks to technical and analytical tools, protein formulation and process development is becoming more efficient. Drug deliveries and drug administration routes are also undergoing a process of innovation.